as Chief Medical Officer
NH TherAguix (« NHT »), a French clinical biotech specialized in the development of innovative nanomedicines for the treatment of cancer by radiotherapy, announces today the arrival of Dr. Olivier de Beaumont as Chief Medical Officer from September 22.